Kura Oncology, Inc. (KURA) SEC filings
KURA SEC filings moved a median of -0.35% by the close. KURA SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the KURA overview →
69 measured KURA SEC filing events.
Where these KURA SEC filings landedvs 69 measured KURA SEC filing reactions
| Middle 50% of KURA SEC filing reactions | -2.24% to +3.74% |
|---|---|
| Median reaction (to close) | -0.35% |
| Measured reactions | 69 |
Point-in-time · zero look-ahead
Half of the 69 KURA SEC filing events with a measured close landed between -2.24% and +3.74%; 45% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K Kura Oncology, Inc. For: Sep 09 | SEC filing · Form 8-K | -0.56% | -3.28% | |
| Form 8-K Kura Oncology, Inc. For: Sep 08 | SEC filing · Form 8-K | -2.10% | -2.72% | |
| Form 10-Q Kura Oncology, Inc. For: Jun 30 | SEC filing · Form 10-Q | +6.00% | -5.35% | |
| Form 8-K Kura Oncology, Inc. For: Aug 12 | SEC filing · Form 8-K | +6.00% | -5.35% | |
| Form 8-K Kura Oncology, Inc. For: Jul 24 | SEC filing · Form 8-K | +2.35% | +4.14% | |
| Form 8-K Kura Oncology, Inc. For: Jun 04 | SEC filing · Form 8-K | +0.63% | -0.23% | |
| Form S-8 Kura Oncology, Inc. | SEC filing · Form S-8 | +0.63% | -0.23% | |
| Form DEFA14A Kura Oncology, Inc. | SEC filing · Form DEFA14A | -0.86% | -1.63% | |
| Form 10-Q Kura Oncology, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.45% | +5.69% | |
| Form 8-K Kura Oncology, Inc. For: May 12 | SEC filing · Form 8-K | +0.45% | +5.69% | |
| Form ARS Kura Oncology, Inc. For: Dec 31 | SEC filing · Form ARS | +0.92% | +0.23% | |
| Form DEF 14A Kura Oncology, Inc. For: Jun 04 | SEC filing · Form DEF | +0.92% | +0.23% | |
| Form DEFA14A Kura Oncology, Inc. | SEC filing · Form DEFA14A | +0.92% | +0.23% | |
| Form 10-K Kura Oncology, Inc. For: Dec 31 | SEC filing · Form 10-K | -1.39% | +7.31% | |
| Form 8-K Kura Oncology, Inc. For: Mar 05 | SEC filing · Form 8-K | -1.39% | +7.31% | |
| Form 8-K Kura Oncology, Inc. For: Jan 28 | SEC filing · Form 8-K | +2.35% | +0.49% | |
| Form 8-K Kura Oncology, Inc. For: Jan 11 | SEC filing · Form 8-K | -0.69% | -2.24% | |
| Form 8-K Kura Oncology, Inc. For: Dec 02 | SEC filing · Form 8-K | +0.00% | -3.13% | |
| Form 10-Q Kura Oncology, Inc. For: Sep 30 | SEC filing · Form 10-Q | -1.62% | +7.79% | |
| Form 8-K Kura Oncology, Inc. For: Nov 04 | SEC filing · Form 8-K | -1.62% | +7.79% | |
| Form S-8 Kura Oncology, Inc. | SEC filing · Form S-8 | -1.62% | +7.79% | |
| Form 8-K Kura Oncology, Inc. For: Oct 24 | SEC filing · Form 8-K | +0.86% | +3.97% | |
| Form 8-K Kura Oncology, Inc. For: Oct 15 | SEC filing · Form 8-K | +2.12% | -0.81% | |
| Form 10-Q Kura Oncology, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.17% | -2.81% | |
| Form 8-K Kura Oncology, Inc. For: Aug 07 | SEC filing · Form 8-K | +0.17% | -2.81% | |
| Form 8-K Kura Oncology, Inc. For: Jun 27 | SEC filing · Form 8-K | -2.09% | -2.61% | |
| Form 8-K Kura Oncology, Inc. For: Jun 12 | SEC filing · Form 8-K | -0.66% | -4.25% | |
| Form 8-K Kura Oncology, Inc. For: Jun 05 | SEC filing · Form 8-K | -1.68% | -1.90% | |
| Form S-8 Kura Oncology, Inc. | SEC filing · Form S-8 | -1.68% | -1.90% | |
| Form 8-K Kura Oncology, Inc. For: Jun 01 | SEC filing · Form 8-K | -2.23% | +2.07% | |
| Study Featured at ASCO 2025 Highlights Potential New Treatment for Aggressive Form of Acute Myeloid Leukemia | Press release | +0.09% | -0.35% | |
| Form 10-Q Kura Oncology, Inc. For: Mar 31 | SEC filing · Form 10-Q | +1.93% | +3.85% | |
| Form 8-K Kura Oncology, Inc. For: May 01 | SEC filing · Form 8-K | +1.93% | +3.85% | |
| Form ARS Kura Oncology, Inc. For: Dec 31 | SEC filing · Form ARS | -0.51% | +5.82% | |
| Form DEF 14A Kura Oncology, Inc. For: Jun 05 | SEC filing · Form DEF | -1.53% | -0.68% | |
| Form DEFA14A Kura Oncology, Inc. | SEC filing · Form DEFA14A | -1.53% | -0.68% | |
| Form 10-K Kura Oncology, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.32% | -7.29% | |
| Form S-8 Kura Oncology, Inc. | SEC filing · Form S-8 | +0.32% | -7.29% | |
| Form 8-K Kura Oncology, Inc. For: Feb 26 | SEC filing · Form 8-K | -0.50% | -4.01% | |
| Form 8-K Kura Oncology, Inc. For: Feb 05 | SEC filing · Form 8-K | -4.29% | +8.22% | |
| Form 8-K Kura Oncology, Inc. For: Jan 13 | SEC filing · Form 8-K | -1.45% | -4.36% | |
| Form 8-K Kura Oncology, Inc. For: Jan 01 | SEC filing · Form 8-K | +0.90% | -2.51% | |
| Form 8-K Kura Oncology, Inc. For: Dec 16 | SEC filing · Form 8-K | -1.66% | -1.11% | |
| Form 8-K Kura Oncology, Inc. For: Nov 20 | SEC filing · Form 8-K | -1.06% | -14.46% | |
| Form 10-Q Kura Oncology, Inc. For: Sep 30 | SEC filing · Form 10-Q | +1.73% | +5.43% | |
| Form 8-K Kura Oncology, Inc. For: Nov 07 | SEC filing · Form 8-K | +1.73% | +5.43% | |
| Form 8-K Kura Oncology, Inc. For: Sep 13 | SEC filing · Form 8-K | +0.05% | +0.40% | |
| Form 10-Q Kura Oncology, Inc. For: Jun 30 | SEC filing · Form 10-Q | -0.10% | -1.20% | |
| Form 8-K Kura Oncology, Inc. For: Aug 08 | SEC filing · Form 8-K | -0.10% | -1.20% | |
| Form 8-K Kura Oncology, Inc. For: Jun 05 | SEC filing · Form 8-K | -1.25% | -1.88% | |
| Form S-8 Kura Oncology, Inc. | SEC filing · Form S-8 | -1.25% | -1.88% | |
| Form 8-K Kura Oncology, Inc. For: May 24 | SEC filing · Form 8-K | +0.09% | +0.00% | |
| Form 10-Q Kura Oncology, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.49% | +0.39% | |
| Form 8-K Kura Oncology, Inc. For: May 02 | SEC filing · Form 8-K | +0.49% | +0.39% | |
| Form ARS Kura Oncology, Inc. For: Dec 31 | SEC filing · Form ARS | +0.63% | -0.45% | |
| Form DEF 14A Kura Oncology, Inc. For: Apr 12 | SEC filing · Form DEF | +0.03% | -2.86% | |
| Form DEFA14A Kura Oncology, Inc. | SEC filing · Form DEFA14A | +0.03% | -2.86% | |
| Form 10-K Kura Oncology, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.97% | -1.70% | |
| Form 8-K Kura Oncology, Inc. For: Feb 27 | SEC filing · Form 8-K | +0.97% | -1.70% | |
| Form S-8 Kura Oncology, Inc. | SEC filing · Form S-8 | +0.97% | -1.70% | |
| Form EFFECT Kura Oncology, Inc. | SEC filing · Form EFFECT | +1.59% | +3.74% | |
| Form S-3 Kura Oncology, Inc. | SEC filing · Form S-3 | +1.33% | +2.67% | |
| Form D Kura Oncology, Inc. | SEC filing · Form D | -0.17% | -1.58% | |
| Form 8-K Kura Oncology, Inc. For: Jan 30 | SEC filing · Form 8-K | +11.39% | +12.52% | |
| Form 8-K Kura Oncology, Inc. For: Jan 24 | SEC filing · Form 8-K | -1.01% | +4.79% | |
| Form 8-K Kura Oncology, Inc. For: Dec 18 | SEC filing · Form 8-K | +1.89% | +3.32% | |
| Form 10-Q Kura Oncology, Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.57% | +2.85% | |
| Form 8-K Kura Oncology, Inc. For: Nov 02 | SEC filing · Form 8-K | +0.57% | +2.85% | |
| Form S-3ASR Kura Oncology, Inc. | SEC filing · Form S-3ASR | +0.57% | +2.85% |
Keep exploring
More KURA: earnings → · analyst actions → · KURA overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| MIRAGEN THERAPEUTICS INC (MGEN) | 369 | -0.39% | 39% |
| Penumbra, Inc. (PEN) | 369 | +0.06% | 60% |
| Arcus Biosciences, Inc. (RCUS) | 368 | -0.09% | 45% |
| Ligand Pharmaceuticals Incorporated (LGND) | 367 | +0.06% | 52% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.